Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Expert Review of Cardiovascular Therapy|August 1, 2008
Under pressure: future prospects in hypertension management. Interview by Laura DormerHans R BrunnerJournal of Human Hypertension|April 23, 2002
The new oral angiotensin II antagonist olmesartan medoxomil: a concise overviewHans R BrunnerVascular Health and Risk Management|February 28, 2007
Olmesartan medoxomil: current status of its use in monotherapyHans R BrunnerJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|August 22, 2003
Clinical efficacy of olmesartan medoxomilHans R Brunner, Petra LaeisClinical Drug Investigation|December 14, 2006
Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil in achieving 24-hour blood pressure reductions and ambulatory blood pressure goalsHans R Brunner, Kikuo ArakawaAmerican Journal of Physiology. Heart and Circulatory Physiology|September 27, 2003
Determination of cardiac contractility in awake unsedated mice with a fluid-filled catheterQing Wang, Hans R Brunner, Michel BurnierClinical Drug Investigation|May 31, 2007
Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil assessed by 24-hour ambulatory blood pressure monitoring in patients with essential hypertensionHans R Brunner, Klaus O Stumpe, Andrzej JanuszewiczJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|August 22, 2003
Monitoring compliance in resistant hypertension: an important step in patient managementMichel Burnier, Valérie Santschi, Bernard Favrat, et al.Journal of Biomedicine & Biotechnology|September 17, 2003
Rapid Site-Directed Mutagenesis Using Two-PCR-Generated DNA Fragments Reproducing the Plasmid TemplateFlore Allemandou, Jürg Nussberger, Hans R. Brunner, et al.Pageof 5